Saturday 6 November 2021 | 12:00–13:00 GMT / 13:00–14:00 CET
Live online talk lasting 60 minutes including live Q&A.In partnership with GASCDO Like the Novartis Sub-Saharan Africa Facebook page to be notified once the event is live
In this webinar, we will talk about how to prevent the childhood mortality caused by Sickle Cell
Disease (SCD) in Sub-Saharan Africa by introducing the newborn screening programme for SCD.
Special guest speakers:
Dr Charles Kiyaga: Director of Programs and Partnerships at the Department of Laboratory and Diagnostic Services, and the National Sickle Cell Program Coordinator at the Ministry of Health
Uganda. Dr Charles Kiyaga initiated and runs the National Sickle Cell Program in Uganda
Dr Lawrence Osei-Tutu: A specialist clinical paediatric haematologist-oncologist at the Komfo Anokye Teaching Hospital (KATH) in Kumasi, Ghana. Dr Lawrence Osei-Tutu has established a
sickle cell clinic that offers hydroxyurea therapy to about 120 children, adolescents and adults,
under the Ghana-Novartis Hydroxyurea for Sickle Cell (Ahodwo) programme
Samuel Misiani Mbunya: The leader of the SCD advocacy pillars, the Ministry of Health,
Kenya. Advocacy Relations Consultant – Haemophillia & Sickle Cell Disease Programs – Kenya at Indiana Haemophilia and Thrombosis Center, Inc. (USA, with the base in Sweden for Kenya programmes). Member Board of Directors – Global Alliance of Sickle Cell Disease Organizations (GASCDO)
Chilufya Pikiti: Founding member of the ZACCAF – Zambian Childhood Cancer Foundation/
Haemophilia Foundation of Zambia
